• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HLA-DQ 错配可刺激心脏移植受者产生新的供体特异性抗体。

HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.

机构信息

HLA Laboratory, Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.

出版信息

Hum Immunol. 2020 Jul;81(7):330-336. doi: 10.1016/j.humimm.2020.04.003. Epub 2020 Apr 17.

DOI:10.1016/j.humimm.2020.04.003
PMID:32307126
Abstract

The development of donor specific antibody is associated with graft rejection and increased mortality in solid organ transplant recipients. The majority of de novo donor specific antibodies (dnDSA) are against HLA-DQ antigens, but it has not been investigated if this is caused by more mismatches in the HLA-DQ locus between the recipient and donor. Here we examined the impact of HLA mismatches in eight HLA loci on the development of dnDSA and on rejection in a large cohort of heart transplant recipients. We evaluated HLA mismatches at the antigen level, the eplet level using HLAMatchmaker, and the epitope level using the PIRCHE algorithm. We found that the majority of dnDSA were against HLA-DQ antigens, and the number of dnDSA per mismatch is highest for HLA-DQ compared to other HLA loci. Furthermore, mismatches of HLA-DQ at the epitope level were associated with antibody-mediated rejection. Our results suggest that HLA mismatches at the HLA-DQ locus are more immunogenic than mismatches at other HLA loci to stimulate the development of dnDSA and to cause graft rejection.

摘要

供体特异性抗体的产生与实体器官移植受者的移植物排斥和死亡率增加有关。大多数新出现的供体特异性抗体(dnDSA)针对 HLA-DQ 抗原,但尚未研究这是否是由于受者和供者之间 HLA-DQ 基因座中更多的错配引起的。在这里,我们在一个大型心脏移植受者队列中研究了八个 HLA 基因座中 HLA 错配对 dnDSA 形成和排斥的影响。我们评估了抗原水平、HLAMatchmaker 中的 eplet 水平和 PIRCHE 算法中的表位水平的 HLA 错配。我们发现大多数 dnDSA 针对 HLA-DQ 抗原,与其他 HLA 基因座相比,每个错配的 dnDSA 数量在 HLA-DQ 中最高。此外,HLA-DQ 表位水平的错配与抗体介导的排斥反应有关。我们的结果表明,HLA-DQ 基因座上的 HLA 错配比其他 HLA 基因座上的错配更具免疫原性,从而刺激 dnDSA 的产生并导致移植物排斥。

相似文献

1
HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.HLA-DQ 错配可刺激心脏移植受者产生新的供体特异性抗体。
Hum Immunol. 2020 Jul;81(7):330-336. doi: 10.1016/j.humimm.2020.04.003. Epub 2020 Apr 17.
2
Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.HLA 表位错配对肾移植后新的供体特异性抗体形成的影响。
Transplant Proc. 2024 Apr;56(3):515-520. doi: 10.1016/j.transproceed.2024.01.030. Epub 2024 Feb 16.
3
Eplet Mismatch Load and Occurrence of Donor-Specific Anti-HLA Antibodies, Rejection, and Graft Failure after Kidney Transplantation: An Observational Cohort Study.Eplet 错配负荷与供体特异性抗 HLA 抗体、排斥反应和肾移植后移植物失败的发生:一项观察性队列研究。
J Am Soc Nephrol. 2020 Sep;31(9):2193-2204. doi: 10.1681/ASN.2020010019. Epub 2020 Aug 6.
4
Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.HLA Ⅱ类表位匹配:降低供者特异性抗体产生和改善预后的策略
Am J Transplant. 2013 Dec;13(12):3114-22. doi: 10.1111/ajt.12478. Epub 2013 Oct 25.
5
HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.小儿肝移植中的人类白细胞抗原、非人类白细胞抗原抗体及表位错配:来自一个小型单中心队列的观察结果
Exp Clin Transplant. 2019 Jan;17(Suppl 1):6-17. doi: 10.6002/ect.MESOT2018.L30.
6
High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation.高危 HLA-DQ 错配与肺移植后不良结局相关。
Transpl Int. 2024 Sep 19;37:13010. doi: 10.3389/ti.2024.13010. eCollection 2024.
7
Human leukocyte antigen epitope mismatch loads and the development of de novo donor-specific antibodies in cardiothoracic organ transplantation.人心白细胞抗原表位错配负荷与心脏和胸部器官移植中供体特异性抗体的新发。
Int J Immunogenet. 2022 Feb;49(1):30-38. doi: 10.1111/iji.12563. Epub 2021 Dec 14.
8
Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation.在胰肾联合移植中,Eplet 错配评分与新生供者特异性抗体的产生。
Hum Immunol. 2021 Mar;82(3):139-146. doi: 10.1016/j.humimm.2020.12.009. Epub 2020 Dec 31.
9
Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.使用DR和DQ表位错配进行小儿肾移植供体选择:一种新的组织相容性模式。
Pediatr Transplant. 2016 Nov;20(7):926-930. doi: 10.1111/petr.12762. Epub 2016 Jul 22.
10
Identification of risk epitope mismatches associated with de novo donor-specific HLA antibody development in cardiothoracic transplantation.鉴定与心胸器官移植中供体特异性 HLA 抗体新生发展相关的风险表位错配。
Am J Transplant. 2018 Dec;18(12):2924-2933. doi: 10.1111/ajt.14951. Epub 2018 Jun 22.

引用本文的文献

1
Belatacept-based immunosuppression in heart transplant recipients: A single center experience.心脏移植受者中基于贝拉西普的免疫抑制:单中心经验
JHLT Open. 2025 May 22;9:100277. doi: 10.1016/j.jhlto.2025.100277. eCollection 2025 Aug.
2
Cutting to the chase: Pruning alloreactive T cells.切入正题:清除同种反应性T细胞。
Immunity. 2025 Feb 11;58(2):270-272. doi: 10.1016/j.immuni.2025.01.005.
3
Surveillance donor-specific antibody and pathologic antibody-mediated rejection testing in heart transplant patients in the contemporary era.
当代心脏移植患者中监测供体特异性抗体及病理抗体介导的排斥反应检测
J Heart Lung Transplant. 2025 Jul;44(7):1036-1049. doi: 10.1016/j.healun.2025.01.019. Epub 2025 Feb 4.
4
High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation.高危 HLA-DQ 错配与肺移植后不良结局相关。
Transpl Int. 2024 Sep 19;37:13010. doi: 10.3389/ti.2024.13010. eCollection 2024.
5
New insights into maladaptive vascular responses to donor specific HLA antibodies in organ transplantation.器官移植中对供体特异性HLA抗体的适应性血管反应的新见解。
Front Transplant. 2023 Apr 28;2:1146040. doi: 10.3389/frtra.2023.1146040. eCollection 2023.
6
Pseudomonas aeruginosa infection correlates with high MFI donor-specific antibody development following lung transplantation with consequential graft loss and shortened CLAD-free survival.铜绿假单胞菌感染与肺移植后高 MFI 供体特异性抗体的发展相关,导致移植物丢失和 CLAD 无进展生存期缩短。
Respir Res. 2024 Jul 1;25(1):262. doi: 10.1186/s12931-024-02868-1.
7
Assessment of IgM DSAs in Transplant Recipients: Relationship to De Novo IgG DSAs and Risk for Antibody Rejection.移植受者中IgM供者特异性抗体的评估:与新发IgG供者特异性抗体的关系及抗体介导排斥反应的风险
Transplant Direct. 2024 Feb 16;10(3):e1583. doi: 10.1097/TXD.0000000000001583. eCollection 2024 Mar.
8
Donor-Specific Antibody Testing is an Effective Surveillance Strategy for High-Risk Antibody Mediated Rejection in Heart Transplant Patients in the Contemporary Era.供者特异性抗体检测是当代心脏移植患者中高危抗体介导排斥反应的有效监测策略。
medRxiv. 2024 Oct 1:2023.12.01.23299311. doi: 10.1101/2023.12.01.23299311.
9
De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians.心脏移植术后新发供者特异性抗体:临床医生综合指南
J Clin Med. 2023 Dec 2;12(23):7474. doi: 10.3390/jcm12237474.
10
Selection and Interpretation of Molecular Diagnostics in Heart Transplantation.心脏移植中的分子诊断选择与解读。
Circulation. 2023 Aug 22;148(8):679-694. doi: 10.1161/CIRCULATIONAHA.123.062847. Epub 2023 Aug 21.